Stomach Diseases  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00002615: Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

Completed
3
500
Europe
cisplatin, epirubicin hydrochloride, fluorouracil, conventional surgery
Medical Research Council
Gastric Cancer
 
12/03
GASTRANOX, NCT00718354: Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT

Completed
3
740
RoW
Enoxaparin, Standard Chemotherapy, Some commonly prescribed Chemotherapy regimens in India are:, - Epirubicin + Cisplatin + Capecitabine, - Capecitabine + Oxaliplatin, - Docetaxil + Carboplatin, - Epirubicin + Cisplatin + Fluorouracil, - Docetaxil + Cisplatin with G/C/S/F support, - Epirubicin + Cisplatin + Flourouracil, - Docetaxil + Cisplatin + Flourouracil
Thrombosis Research Institute
Gastric Cancer, Gastroesophageal Cancer
01/10
08/10
NCT00123318: A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer

Completed
3
52
RoW
epirubicin, Epirubicin Ebewe, Epirubicin Hydrochloride for Injection, cisplatin, Cisplatin Ebewe, Cisplatin Injection, 5-fluorouracil, DBL Fluoruracil Injection BP, Efudix, Radiotherapy, Radiation
Trans Tasman Radiation Oncology Group, The Royal Australian and New Zealand College of Radiologists
Gastric Cancer
02/12
02/12
REAL3, NCT00824785 / 2007-005976-15: Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Checkmark
Apr 2013 - Apr 2013: 
Checkmark Biomarker data
More
Terminated
3
574
Europe
epirubicin, oxaliplatin, capecitabine (EOX), EOX + panitumumab
Royal Marsden NHS Foundation Trust
Oesophago-gastric Cancer
02/13
02/13
RILOMET-1, NCT01697072 / 2011-004923-11: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Terminated
3
609
US, Canada, Europe, RoW
Rilotumumab, AMG102, Placebo, sterile protein-free solution, Epirubicin, Ellence, Pharmorubicin PFS, Pharmorubicin RDF, Cisplatin, Platinol, Platinol-AQ, Capecitabine, Xeloda
Amgen
Gastric Cancer
11/14
08/15
CRITICS, NCT00407186 / 2006-004130-32: Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer

Active, not recruiting
3
788
Europe
cisplatin+capecitabine, radiotherapy, epirubicin+cisplatin+capecitabine
Dutch Colorectal Cancer Group, The Netherlands Cancer Institute, Roche Pharma AG
Gastric Cancer
12/18
12/25

Download Options